Literature DB >> 1148891

Chemical and morphologic alterations of rabbit bone induced by adriamycin.

D M Young, J L Fioravanti, H M Olson, D J Prieur.   

Abstract

Long term, low dose administration of adriamycin (ADR) to young growing rabbits resulted in significant alterations in bone structure and chemistry. Morphologic changes were most pronounced at epiphyseal and metaphyseal areas of long bones. Epiphyseal cartilage plates were thin and there was derangement of growth zones. Areas of primary and secondary spongiosa were deficient in trabeculae, osteoblasts and osteoclasts. Analysis of femora, humeri and lumbar vertebrae from ADR-treated rabbits revealed increased water and fat content and significant decreases in bone density compared to age-matched controls. Cortices of long bones were roentgenographically thin and contained large irregular spaces evident microscopically. Evaluation of bone ash from ADR treated rabbits revealed significant increases in the percentage of calcium and phosphorus, although Ca/P ratios were not different from controls. Results of in vitro studies indicate that ADR binds readily to nondemineralized, but not demineralized, fresh cortical bone powder. The findings of decreased bone density, histopathologic alterations, and a paucity of osteogenic cells in ADR treated rabbits are interpreted as retardation of bone maturation. It is suggested that ADR affects adversely both the organic and inorganic fractions of bone. Due to its unique characteristics of cytostatic action, binding to metal cations and orange-red fluorescence, ADR is a novel chemical agent that may be useful in experimental bone studies.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1148891     DOI: 10.1007/bf02546226

Source DB:  PubMed          Journal:  Calcif Tissue Res        ISSN: 0008-0594


  28 in total

1.  An automatic method for colorimetric analysis.

Authors:  L T SKEGGS
Journal:  Am J Clin Pathol       Date:  1957-09       Impact factor: 2.493

2.  The water content of bone. I. The mass of water, inorganic crystals, organic matrix, and CO2 space components in a unit volume of the dog bone.

Authors:  S R ELLIOTT; R A ROBINSON
Journal:  J Bone Joint Surg Am       Date:  1957-01       Impact factor: 5.284

3.  The calcium tolerance of growing and reproducing rabbits.

Authors:  R E Chapin; S E Smith
Journal:  Cornell Vet       Date:  1967-07

Review 4.  Bone mineral on the molecular level.

Authors:  A S Posner
Journal:  Fed Proc       Date:  1973-09

Review 5.  The cellular basis of metabolic bone disease.

Authors:  H Rasmussen; P Bordier
Journal:  N Engl J Med       Date:  1973-07-05       Impact factor: 91.245

Review 6.  Drugs toxic to bone.

Authors:  W Y Au; L G Raisz
Journal:  Semin Drug Treat       Date:  1972

7.  Mithramycin in the treatment of Paget's disease of bone.

Authors:  E G Elias; J T Evans
Journal:  J Bone Joint Surg Am       Date:  1972-12       Impact factor: 5.284

Review 8.  Bone disease in uremia.

Authors:  S W Stanbury
Journal:  Am J Med       Date:  1968-05       Impact factor: 4.965

9.  Endochondral (provisional) calcification in vitro. The effect of some metabolic inhibitors.

Authors:  U S Barzel; R Morecki; I Spigland
Journal:  Clin Orthop Relat Res       Date:  1971       Impact factor: 4.176

10.  Effect of actinomycin D on epiphyseal plate of mice. A histological and 35S-autoradiographic study.

Authors:  A Hulth; L Lindberg
Journal:  Acta Pathol Microbiol Scand       Date:  1968
View more
  6 in total

1.  Adriamycin inhibits PTH-mediated but not PGE2-mediated stimulation of cyclic AMP formation in isolated bone cells.

Authors:  G Kohler; V Shen; W A Peck
Journal:  Calcif Tissue Int       Date:  1984-05       Impact factor: 4.333

2.  Effects of doxorubicin administration on bone strength and quality in sedentary and physically active Wistar rats.

Authors:  H Fonseca; A Carvalho; J Esteves; V I Esteves; D Moreira-Gonçalves; J A Duarte
Journal:  Osteoporos Int       Date:  2016-06-18       Impact factor: 4.507

3.  Evaluation of bone toxicity in various bones of aged rats.

Authors:  Chihiro Noguchi; Hiroto Miyata; Yasushi Sato; Yoshinobu Iwaki; Shigeru Okuyama
Journal:  J Toxicol Pathol       Date:  2011-03-31       Impact factor: 1.628

4.  Doxorubicin-mediated bone loss in breast cancer bone metastases is driven by an interplay between oxidative stress and induction of TGFβ.

Authors:  Tapasi Rana; Anwesa Chakrabarti; Michael Freeman; Swati Biswas
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

5.  Doxorubicin Induces Bone Loss by Increasing Autophagy through a Mitochondrial ROS/TRPML1/TFEB Axis in Osteoclasts.

Authors:  Hyun-Jung Park; Sun-Young Yoon; Jung-Nam Park; Jae-Hee Suh; Hye-Seon Choi
Journal:  Antioxidants (Basel)       Date:  2022-07-28

6.  Cytotoxic agents are detrimental to bone formed by distraction osteogenesis.

Authors:  Fergal P Monsell; James Ralph Barnes; M C Bellemore; L Biston; Allen Goodship
Journal:  Strategies Trauma Limb Reconstr       Date:  2013-10-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.